- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Innate Pharma SA (IDD)
| Open: | 2.537 | Day's Range: | 2.537 - 2.537 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 2.538 | 52wk Range: | 1.377 - 2.891 | 1-Yr Rtn: | +53.57% |
Key Statistics for IDD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | -0.1200 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/19/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IDD
Company Profile & Key Executives for IDD
Innate Pharma S.A. is a biopharmaceutical company. The Company develops first in class drugs that focus on cancer immunotherapy through the manipulation of the innate immune system.
| Herve BraillyChairman-Mgmt Board/CEO/Co-Founder | Jerome TiollierExec VP/Chief Dev Officer |
| Marcel RozencweigExec VP/Chief Medical Officer | Francois RomagneExec VP/Chief Scientific Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IDD News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page